Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • The Richmond Dental: A State-of-the-Art Dental Centre by Dr. Hajira Nazeer Business
  • Intense Technologies Posts Q1 FY26 Revenue of Rs 3,148 Lakhs with 4 Major Client Wins Business
  • From Bet to Triumph: A Cross-Coast Celebration of ‘ROCKETRY – THE NAMBI EFFECT Entertainment
  • SGT University Hosts Scholarship Distribution Ceremony to Support and Empower Meritorious Students Education
  • FTA with EFTA to Power India’s Global Trade Momentum from 1st Oct 2025 National
  • Arbour Investments strikes INR 75 Crore Investment deal with Maharaja Dream Homes in Dombivli, sets New Governance Benchmark for Affordable Housing Press Release
  • The Limitless and Unstoppable Journey of Saasy Shweta Lifestyle
  • Digisharks Communications Pvt Ltd hosted a fantastic Diwali party for its employees and announced the National Achievers Awards 2022 Lifestyle

JFL Life Sciences Limited files Prospectus with NSE EMERGE

Posted on August 18, 2022 By

New Delhi (India), August 18: JFL Life Sciences Limited, engaged in the business of manufacturing pharmaceutical products having an experience for more than a decade, has filed the prospectus with NSE EMERGE to raise Rs 1,816.58 Lakhs through an initial public offering (IPO).

The public issue of JFL Life Sciences Limited is for 29,78,000 equity shares of Face Value ₹10 each (“EQUITY SHARES”) for cash at a price of ₹ 61/- per equity share (including a securities premium of ₹ 51/- per equity share) (the issue price) aggregating ₹ 1,816.58 LACS of the issue. 1,50,000 equity shares aggregating to ₹ 91.50 Lakhs will be reserved for market maker (“Market Maker Reservation Portion”). The issue, less the Market Maker Reservation Portion, i.e., issue of 28,28,000 equity shares of Face Value of ₹ 10/- EACH at an issue price of ₹ 61/- per equity share, aggregating to ₹ 1,725.08 Lakhs, which is hereinafter referred to as “The Net Issue”. The issue and the Net Issue will constitute 27.08% AND 25.71%, respectively of the post issue paid up equity share capital of the company. The company will list at NSE Emerge. The Lead manager of the issue is GYR Capital Advisors Pvt Ltd and the Registrar to the issue is KFin Technologies Ltd.

The company intends to utilize the proceeds of the Issue to meet the following objectives:

  1. Repayment of secured and unsecured loans
  2. Funding the working capital requirements of the company
  3. General Corporate Purposes

JFL Life Sciences Limited is engaged in the business of manufacturing pharmaceutical products. Their product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).With market presence in pan India, products of JFL supplies to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and an FDA approved state of the art manufacturing facility near Ahmedabad.

The Company has registered their products to manufacture in various countries like sovereign of Kenya, Nigeria, Yemen, & Myanmar. Few of their products are also registered with Ukraine, Uzbekistan, and Kazakhstan as well. This builds a moat around their business. This also makes them a ‘one-stop-shop’ service provider for catering to all of the customer’s needs domestically as well as internationally.

The promoters, Mr. Smiral Ashwinbhai Patel and Tejal Smiralbhai Patel are actively involved in the day-to-day business of the company and are the guiding force behind the strategic decisions for the Company. Their management team and other key management personnel are well qualified and have extensive industry expertise, and have been responsible for the operational growth.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: Gujarat based Rhetan TMT’s Rs. 56 crore public issue on BSE SME platform opens for subscription on August 22
Next Post: Start your medical studies in India without NEET; applications are still open for St. George’s University (SGU) in association with the Ramaiah Group of Institutions

Related Posts

  • Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489% Business
  • Cupid Limited Strengthens IVD Test Kits Business with Certification Pipeline, Capacity Expansion, and Global Market Expansion Business
  • Abdominal Cancer Day Founded by Dr Sundeep Jain celebrated worldwide on May 19th Business
  • Faith Services Pvt. Ltd. – India’s Innovator in Scaffolding, Walkway Systems & Formwork Excellence Business
  • Hitech BillSoft: One of India’s Fastest Growing Free Lifetime Billing Software for SMEs Business
  • Royal Cosmognathics Pioneers Cutting-Edge Mouth Cancer Treatment with CBCT Technology Business

Recent Posts

  • 25 Hindi Suspense Thrillers That Didn’t Just Twist Plots — They Twisted You
  • Rs 250 Crore and Counting: Shah Rukh Khan’s ‘King’ Isn’t a Film — It’s a Statement
  • Citadel Season 2: Memory Is Optional, Consequences Are Not
  • Surat Witnesses One of India’s Grandest Fashion Show Experiences with ‘Fashion Show 2026’ by Red & White Skill Education
  • Dosti Greater Thane Celebrates the Unveiling of Its Ganesh Temple

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Fossil Remedies Offers Best Pharmaceutical Products & Professional Quality Services At Affordable Prices Business
  • SaaS Procurement in 2024 Powered By Fineshift: Why Businesses Need a Solution Like SaaSOTY to Stay Ahead? Business
  • Ashlesha Thakur’s period Drama Film ‘Shantala’ Will Be Released on December 15 – Mahesh Bhatt Entertainment
  • Talent Formula Opens New Office in Coimbatore, India with a Vision of Global Expansion Business
  • Travel Insurance Online India: Your Complete Guide to Choosing the Right International Plan for Schengen & USA Trips Business
  • Shreeji Shipping Registers Robust Q1 FY26 Performance; EBITDA Margin Rises by 811 bps Business
  • Shrimad Rajchandra Hospital’s camp helps Nearly 25 thousand patients National
  • Sky Gold Limited reported Q3FY23 net profit of Rs.11.67 crore Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme